TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Performance with word stimuli
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: increase in negative mood
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Complications reported with polidocanol
Endpoint domain: Adverse events/effects
Primary endpoint: Cerebral amyloid burden
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Global cognitive performance
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Defervescence speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fatigue frequency
Endpoint domain: Adverse events/effects
Primary endpoint: Concentration of PVP-iodine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PEP index score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Event-free survival at 1 year
Endpoint domain: Mortality/survival
Primary endpoint: distant recurrence-free survival
Endpoint domain: Mortality/survival
Primary endpoint: Risk of stroke from any cause
Endpoint domain: Mortality/survival
Primary endpoint: Risk of nonhemorrhagic stroke
Endpoint domain: Mortality/survival
Primary endpoint: improvements in impairment
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: global ratings
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: granola bar intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: number of defecations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: effectiveness of high-power ultrasound
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: length of therapy
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: pain intensity during shoulder flexion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pain-free shoulder flexion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maximum shoulder flexion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Enrolment in education over 6 months
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Duration of employment over 6 months
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Total hours of paid work over 6 months
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Range of motion (ROM) attainment for discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visualization of residual aneurysm patency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevention of nausea, vomiting, and anorexia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Menopausal quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Presence of CPFS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MyoPS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total effectiveness rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: sleepiness levels
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Quality of self-reported screening
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: GI complaints
Endpoint domain: Adverse events/effects
Primary endpoint: Body weight stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fermentation and faecal characteristics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: incidence of nonfatal pulmonary edema
Endpoint domain: Adverse events/effects
Primary endpoint: Mean RNFL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mean neural area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mean C/D ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: small-airway function (z score for FEF75)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Thromboembolic events (TE) risk prediction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: number of episodes of food intolerance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: intake of cereals and meats
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: chewing capacity and swallowing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Tympanic temperature sensitivity and specificity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: double product
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean core temperature at end of surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: core temperature less than 36 degrees C at recovery room arrival
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to fulfill clinical discharging criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceived workplace difficulties
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Screening for CRC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in adhesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in crusting
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Middle turbinate lateralization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean pain intensity levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dose titration period
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 2-year biochemical progression-free survival
Endpoint domain: Mortality/survival
Primary endpoint: PSA nadir of <1 ng/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Central apnoea-hypopnoea index (AHI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: procedural-related complications
Endpoint domain: Adverse events/effects
Primary endpoint: VAS pain intensity reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: walking time improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lateral spine flexion range increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall sexual score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neutrophil phagocytosis index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Neutrophil adhesiveness index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: All-cause re-admission or death
Endpoint domain: Mortality/survival
Primary endpoint: rates of hospital re-admission
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: postoperative ICU admissions
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Increase of CD3, CD4 and CD4/CD8
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Decrease of CD8
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Total effective rate comparison
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: increase in daily meal frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvements in eating disorder symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: high satisfaction with the treatment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Hospitalization for worsening heart failure
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Plasma boron concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvements in resident QoL
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: 6-minute-walk test distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Chronic Respiratory Questionnaire total score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Plasma incremental area under the curve (iAUC) for insulin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Plasma glucose iAUC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Plasma triglyceride iAUC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Intentions to eat healthy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean number of postoperatively transfused blood units
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Proportion of patients receiving blood transfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Eosinophilia
Endpoint domain: Adverse events/effects
Primary endpoint: EGF mRNA levels in leiomyoma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Summed stress score (SSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rest score (SRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rates of Demodex mite relapse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: New lesion occurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of MDR Acinetobacter baumannii
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Efficacy of treatment for severe AD flares
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fewer needle passes required
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Proportion maintaining complete abstinence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: PdetQmax
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Modified Rankin Scale of less than 2 at 3 months
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Compliance with CAM-ICU assessments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reliability of CAM-ICU assessments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dose-dependent radiation injury at the vascular wall level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: HIV-1 transmission rate
Endpoint domain: Mortality/survival
Primary endpoint: Cardiovascular changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Median interval to presumed cure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for ranibizumab injections
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: risk of specific adverse mental health outcomes
Endpoint domain: Adverse events/effects
Primary endpoint: Culture results negative for MRSA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: SAS and SDS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Binocular near visual acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total time with tracheal pH < 5.5
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Incidence of respiratory complications after surgery
Endpoint domain: Adverse events/effects
Primary endpoint: EQ-5D score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Drug survival
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: risk of recurrent cardiovascular events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: PAI‐1 antigen levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: PAI‐1 activity levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: t‐PA antigen levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: leg extensor power
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: marital adjustment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Opportunistic infections rate
Endpoint domain: Adverse events/effects
Primary endpoint: Competence and self-efficacy in communication
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Satisfaction with learning experience
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Daily frequency of symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptomatic effect score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Overall colonic distention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: sperm velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Insomnia diagnostic criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: leptin concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Time to spontaneous recovery to a TOF ratio of 0.9
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IMR(s) values decline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Detection of lipids on soft lenses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urinary sodium concentration excretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: seizure control in partial epilepsy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Volume fraction of blood vessels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Number of vessel cross-sections per unit area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Cross-sectional diameters of the largest vascular lumens
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Reduction in low-density lipoproteins
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduction in triglycerides
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Increase in high-density lipoproteins
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: adverse outcomes during the first 90 days after discharge
Endpoint domain: Adverse events/effects
Primary endpoint: cartilage volume of the knee joint
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: mean changes in the 50CMJ
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean changes in the 50SJ
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean changes in the BJ
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of DA prescribing
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Low-density lipoprotein reductions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: learning deficits
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: perceived memory complaints
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: overall uptake
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Overprescription of antimalarials
Endpoint domain: Adverse events/effects
Primary endpoint: Targeting of antibiotics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Crea threshold for CADI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Viral seroconversions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Bleeding control at recipient site
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Hemoglobin measurements of blood-soaked dressings
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Frequency of discussions on injury prevention topics
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: self-reported symptoms of depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: self-reported symptoms of generalized stress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Incidents of patient-initiated violence
Endpoint domain: Adverse events/effects
Primary endpoint: PANSS-EC total scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of transient LOS relaxations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Oesophageal acid exposure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Clinical recurrence of varicose veins
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Defecations per week
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Two-year rates of ST
Endpoint domain: Mortality/survival
Primary endpoint: Two-year composite rate of cardiac death or MI
Endpoint domain: Mortality/survival
Primary endpoint: Improvement in atopic dermatitis (AD) lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Decrease in Staphylococcus aureus colonization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Students' ability to search databases and retrieve evidence
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Students' satisfaction with the training
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Median breakpoint for candies
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bradycardic effect
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: daily worst pain severity score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: global response assessment improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Spontaneous preterm birth prior to 35 weeks' gestation
Endpoint domain: Mortality/survival
Primary endpoint: Internal anal sphincter fragmentation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Residual skin tags
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perianal pruritus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acceptability of yoga classes for depressed individuals
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percentage decrease in serum uric acid concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: pain relief rates
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: SaO2 change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Mean AUC of retigabine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean terminal half-life of retigabine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean apparent clearance of retigabine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Limb soreness
Endpoint domain: Adverse events/effects
Primary endpoint: Limitation of motion
Endpoint domain: Adverse events/effects
Primary endpoint: short-term cessation rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: withdrawal-related craving
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intestinal hyperpermeability normalization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Adverse effects of local anesthetics
Endpoint domain: Adverse events/effects
Primary endpoint: Antibiotic resistance rates of uropathogens
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: freedom from recurrent AF after ablation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes